Position in EDIT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$264,784
+$40,709 QoQ
Shares Held
107,200
-1.9% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 16.166977611940297.ToString("F0")%
Shared 0.ToString("F0")%
None 83.8330223880597.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. EDIT ranks #192 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in EDIT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $264,784 | 107,200 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $224,075 | 109,305 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $425,165 | 122,526 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $278,957 | 126,799 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $143,666 | 123,850 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $178,710 | 140,717 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $483,793 | 141,875 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $644,394 | 137,986 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $995,200 | 134,124 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,330,940 | 131,386 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,025,068 | 131,419 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $963,395 | 117,059 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $807,773 | 111,417 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $988,898 | 111,488 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,329,349 | 108,607 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,197,822 | 101,253 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,379,805 | 72,545 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,910,776 | 71,969 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,034,620 | 73,871 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,088,841 | 72,190 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,167,094 | 75,407 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $5,590,641 | 79,741 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,088,197 | 74,419 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,551,748 | 86,266 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,468,689 | 74,064 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||